All the news Showing 10 of 1,856 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Harm reduction interventions and policy New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand Filter / 25 April 2019 Hepatitis A Previous HAV vaccination does not reliably protect some patients with HIV Healio / 18 April 2019 Hepatitis C elimination England hits WHO 2020 hepatitis C target three years early The Pharmaceutical Journal / 18 April 2019 NAFLD Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV Infectious Disease Advisor / 17 April 2019 NAFLD Experts warn of fatty liver disease 'epidemic' in young people The Guardian / 12 April 2019 Health expert says hepatitis C could be eliminated quickly in Scotland BBC News / 12 April 2019 Access to medicines & diagnostics Global hepatitis response gains ground – More action needed to achieve universal health coverage targets World Health Organization / 12 April 2019 NAFLD Second-generation thiazolidinedione, MSDC-0602K may significantly improve liver enzymes, fibrosis, and glycaemic markers with minimal adverse events, according to a Phase 2b study EASL / 12 April 2019 Treatment for previous non-responders & relapsers ‘Real-world’ studies in Germany and the USA confirm high rates of sustained virological response with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in individuals with chronic HCV infection failing DAAs EASL / 12 April 2019 Harm reduction interventions and policy Hepatitis C could be prevented worldwide by reducing transmission in people who inject drugs University of Bristol / 12 April 2019 ← First12345...186Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds